United Therapeutics Corp 2025 SR
The report highlights United Therapeutics' progress as a public benefit corporation in 2024, focusing on its mission to expand organ availability and develop rare disease therapies. Key achievements include serving over 15,500 patients, reaching $2.88 billion in revenue, and celebrating the 500th successful lung transplant via its ex vivo lung perfusion service. The company advanced its organ manufacturing platforms, including successful xenotransplants and FDA clearance for bioengineered organ trials. Environmentally, it maintained LEED-certified properties and broke ground on a sustainable mass-timber manufacturing facility. Socially, it maintained a low 4.6% voluntary turnover rate and expanded employee benefits.
Company: United Therapeutics Corp
Sector: Health Care
Country: United States
Year: 2025
Type: SR
Pages: 90
United Therapeutics Corp
Corporate Responsibility And Public Benefit Report
The report highlights United Therapeutics' progress as a public benefit corporation in 2024, focusing on its mission to expand organ availability and develop rare disease therapies. Key achievements include serving over 15,500 patients, reaching $2.88 billion in revenue, and celebrating the 500th successful lung transplant via its ex vivo lung perfusion service. The company advanced its organ manufacturing platforms, including successful xenotransplants and FDA clearance for bioengineered organ trials. Environmentally, it maintained LEED-certified properties and broke ground on a sustainable mass-timber manufacturing facility. Socially, it maintained a low 4.6% voluntary turnover rate and expanded employee benefits.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Sep 12, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Workplace Fatalities
Employees